Company
Prescient Design
Founded2021
Prescient Design developed machine-learning methods for designing proteins and antibodies for drug discovery. Acquired by Genentech in August 2021, its team and platform became part of Genentech and Roche’s AI drug-discovery work.
Former members 1
Related organizations
Based on public sources. If accuracy is important, verify details using the links or references.
For corrections, updates, or requests to remove information, contact us.